{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:31:01Z","timestamp":1781796661157,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Sarcoma Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2045-3329-4-6","type":"journal-article","created":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T03:06:21Z","timestamp":1403924781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Response of follicular dendritic cell sarcoma to gemcitabine and docetaxel: report of two cases and literature review"],"prefix":"10.1186","volume":"4","author":[{"given":"Robert M","family":"Conry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,28]]},"reference":[{"key":"56_CR1","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/eji.201040765","volume":"40","author":"A Aguzzi","year":"2010","unstructured":"Aguzzi A, Krautler NJ: Characterizing follicular dendritic cells: a progress report. Eur J Immunol. 2010, 40: 2134-2138. 10.1002\/eji.201040765","journal-title":"Eur J Immunol"},{"key":"56_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1046\/j.1365-2559.2001.01134.x","volume":"38","author":"AC Chan","year":"2001","unstructured":"Chan AC, Chan KW, Chan JK, Au WY, Ho WK, Ng WM: Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman\u2019s disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology. 2001, 38: 510-518. 10.1046\/j.1365-2559.2001.01134.x","journal-title":"Histopathology"},{"key":"56_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4166\/kjg.2013.62.2.131","volume":"62","author":"SO Hwang","year":"2013","unstructured":"Hwang SO, Lee TH, Bae SH, Cho HD, Choi KH, Park SH, Kim CH, Kim SJ: Transformation of Castleman\u2019s disease into follicular dendritic cell sarcoma, presenting as an asymptomatic intra-abdominal mass. Korean J Gastroenterol. 2013, 62: 131-134. 10.4166\/kjg.2013.62.2.131","journal-title":"Korean J Gastroenterol"},{"key":"56_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4132\/KoreanJPathol.2014.48.2.140","volume":"48","author":"ST Pan","year":"2014","unstructured":"Pan ST, Cheng CY, Lee NS, Liang PI, Chuang SS: Follicular dendritic cell sarcoma of the inflammatory pseudotumor-like variant presenting as a colonic polyp. Korean J Pathol. 2014, 48: 140-145. 10.4132\/KoreanJPathol.2014.48.2.140","journal-title":"Korean J Pathol"},{"key":"56_CR5","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1200\/JCO.2011.37.1906","volume":"29","author":"AB Shinagare","year":"2011","unstructured":"Shinagare AB, Ramaiya NH, Jagannathan JP, Hornick JL, Swanson RS: Primary follicular dendritic cell sarcoma of liver treated with cyclophosphamide, doxorubicin, vincristine, and prednisone regimen and surgery. J Clin Oncol. 2011, 29: e849-e851. 10.1200\/JCO.2011.37.1906","journal-title":"J Clin Oncol"},{"key":"56_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.cell.2012.05.032","volume":"150","author":"NJ Krautler","year":"2012","unstructured":"Krautler NJ, Kana V, Kranich J, Tian Y, Perera D, Lemm D, Schwarz P, Armulik A, Browning JL, Tallquist M, Buch T, Oliveira-Martins JB, Zhu C, Hermann M, Wagner U, Brink R, Heikenwalder M, Aguzzi A: Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell. 2012, 150: 194-206. 10.1016\/j.cell.2012.05.032","journal-title":"Cell"},{"key":"56_CR7","doi-asserted-by":"publisher","first-page":"9425","DOI":"10.1200\/JCO.2004.00.9365","volume":"23","author":"T Khalid","year":"2005","unstructured":"Khalid T, Folman R: Symptoms in cancer patients and an unusual tumor: Case 3. Follicular dendritic cell sarcoma. J Clin Oncol. 2005, 23: 9425-9426. 10.1200\/JCO.2004.00.9365","journal-title":"J Clin Oncol"},{"key":"56_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ijc.21867","volume":"119","author":"JO Bay","year":"2006","unstructured":"Bay JO, Ray-Coquard I, Fayette J, Leyvraz S, Cherix S, Piperno-Neumann S, Chevreau C, Isambert N, Brain E, Emile G, Le Cesne A, Cioffi A, Kwiatkowski F, Coindre JM, Bui NB, Peyrade F, Penel N, Blay JY, : Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. Int J Cancer. 2006, 119: 706-711. 10.1002\/ijc.21867","journal-title":"Int J Cancer"},{"key":"56_CR9","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1200\/JCO.2001.19.15.3483","volume":"19","author":"SR Patel","year":"2001","unstructured":"Patel SR, Gandhi V, Jenkins J, Papadopolous N, Burgess MA, Plager C, Plunkett W, Benjamin RS: Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol. 2001, 19: 3483-3489.","journal-title":"J Clin Oncol"},{"key":"56_CR10","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1200\/JCO.2006.10.4117","volume":"25","author":"RG Maki","year":"2007","unstructured":"Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, Thall PF, Benjamin RS, Baker LH, Hensley ML: Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002[corrected]. J Clin Oncol. 2007, 25: 2755-2763. 10.1200\/JCO.2006.10.4117","journal-title":"J Clin Oncol"},{"key":"56_CR11","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1158\/1078-0432.CCR-13-1275","volume":"19","author":"W Vermi","year":"2013","unstructured":"Vermi W, Giurisato E, Lonardi S, Balzarini P, Rossi E, Medicina D, Bosisio D, Sozzani S, Pellegrini W, Doglioni C, Marchetti A, Rossi G, Pileri S, Facchetti F: Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligands. Clin Cancer Res. 2013, 19: 5027-5038. 10.1158\/1078-0432.CCR-13-1275","journal-title":"Clin Cancer Res"},{"key":"56_CR12","first-page":"211","volume":"27","author":"AM Perry","year":"2013","unstructured":"Perry AM, Nelson M, Sanger WG, Bridge JA, Greiner TC: Cytogenetic abnormalities in follicular dendritic cell sarcoma: report of two cases and literature review. In Vivo. 2013, 27: 211-214.","journal-title":"In Vivo"}],"container-title":["Clinical Sarcoma Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2045-3329-4-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T03:12:07Z","timestamp":1548126727000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalsarcomaresearch.biomedcentral.com\/articles\/10.1186\/2045-3329-4-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,28]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["56"],"URL":"https:\/\/doi.org\/10.1186\/2045-3329-4-6","relation":{},"ISSN":["2045-3329"],"issn-type":[{"value":"2045-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,28]]},"assertion":[{"value":"16 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}